Latest filing published 04 Aug 2026 for Inhibitor Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Francis e. Odonnell Jr.: trading record in brief
Francis e. Odonnell Jr. discloses dealings in 4 companies, chiefly Biodelivery Sciences International Inc, Accentia Biopharmaceuticals Inc and Biovest International Inc. We count 159 filings; the first trade dates from 3 April 2006 and the latest from 4 May 2026.
Market trades split into 12 purchases (€6.0M) and 64 sales (€8.9M). The totals do not cover 3 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 21 share grants and 27 option exercises.
A typical purchase (the median) is worth €14k.
On 4 August 2026 came the latest disclosure, a share grant in Inhibitor Therapeutics, Inc. The latest purchase dates back some time: it was published 3,793 days ago, on 20 June 2016. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Francis e. Odonnell Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Common StockSEC:0001493152-26-035950:0
- 22,500 shares0Common StockSEC:0001103021-20-000085:0
- 11,250 shares@ US$4.533.7% of flowCommon StockSEC:0001103021-20-000075:0
- 16,000 shares@ US$4.455.1% of flowCommon StockSEC:0001103021-20-000064:0
- 20,000 shares@ US$4.225.9% of flowCommon StockSEC:0001103021-20-000058:0
- 38,750 shares@ US$3.609.5% of flowCommon StockSEC:0001103021-20-000052:5
- 30,500 shares@ US$3.637.5% of flowCommon StockSEC:0001103021-20-000052:6
- 62,500 shares0Common StockSEC:0001103021-20-000052:0
- 62,500 shares0Common StockSEC:0001103021-20-000052:1
- 15,000 shares0Common StockSEC:0001103021-20-000052:2
- 15,000 shares0Common StockSEC:0001103021-20-000052:3
- 18,284 shares0Common StockSEC:0001103021-20-000052:4
- 8,000 shares@ US$5.312.0% of flowCommon StockSEC:0001103021-20-000026:0
- 8,000 shares@ US$6.102.2% of flowCommon StockSEC:0001103021-20-000002:0
- 10,000 shares@ US$1.960.9% of flowCommon StockSEC:0001103021-19-000061:0
- 10,000 shares@ US$7.003.2% of flowCommon StockSEC:0001103021-19-000059:0
- 8,000 shares@ US$6.862.1% of flowCommon StockSEC:0001103021-19-000048:0
- 8,000 shares@ US$5.831.8% of flowCommon StockSEC:0001103021-19-000027:0
- 32,500 shares@ US$3.474.4% of flowCommon StockSEC:0001103021-19-000025:0
- 32,500 shares@ US$6.007.5% of flowCommon StockSEC:0001103021-19-000025:1
- 32,500 shares@ US$2.262.9% of flowCommon StockSEC:0001103021-19-000020:0
- 32,500 shares@ US$5.006.3% of flowCommon StockSEC:0001103021-19-000020:1
- 8,000 shares@ US$4.341.4% of flowCommon StockSEC:0001103021-19-000017:0
- 8,000 shares@ US$4.291.3% of flowCommon StockSEC:0001103021-19-000011:0
- 8,000 shares@ US$3.821.2% of flowCommon StockSEC:0001628280-19-009862:0
25 of 157 declarations
